C reactive protein, metabolic syndrome and cardiovascular risk in the Costa Rican population born between 1945 and 1955
DOI:
https://doi.org/10.22458/urj.v12i1.2662Keywords:
C reactive protein, metabolic syndrome, cardiovascular disease, risk factor, central obesity, Costa RicaAbstract
ABSTRACT
Introduction: Several studies have mentioned that there is a relationship between C reactive protein (CRP) and the metabolic syndrome (MS) and that this protein is a risk factor of cardiovascular disease. Objective: We studied the relationship of CRP with MS in the Costa Rican population. Methods: People born in Costa Rica between 1945 and 1955 were included in the study (n = 2273). MS was adapted according to the American Heart Association and National Heart, Lung and Blood Institute definition. Results: The prevalence of MS increased with elevated CRP levels (p < 0,001) and was higher in women (p < 0,001). CRP was independently and positively associated to waist circumference and negatively associated to HDL-cholesterol. The strongest CRP determinant was waist circumference (PSup = 67,8). After adjustment for age, sex, residence area, smoking and alcohol, in the highest quartile of CRP levels (CRP > 4 mg/L), the risk for MS was higher compared with that in the lowest quartile of CRP levels. Cardiovascular risk was higher in people with high levels of CRP. Conclusions: CRP levels is associated with the MS among the born between 1945 and 1955 Costa Rican population. Other studies are necessary to establish the role of CRP in the development of MS and cardiovascular events among Costa Rican population
References
Albert, M. A., Glynn, R. J., & Ridker, P. M. (2003). Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation, 108(2), 161-165. doi:10.1161/01.CIR.0000080289.72166.CF
Arcari, A., Zito, F., Di Castelnuovo, A., De Curtis, A., Dirckx, C., & Arnout, J. (2008). C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project. Journal of Thrombosis and Haemostasis, 6(3), 436-443. doi:10.1111/j.1538-7836.2007.02851.x
Bo, S., Gentile, L., Ciccone, G., Baldi, C., Benini, L., Dusio, F., . . . Pagano, G.F. (2005). The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a Southern-European population-based cohort. Diabetes/Metabolism Research and Reviews, 21(6), 515-524. doi:10.1002/dmrr.561
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., ... Gudnason, V. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350(14), 1387-1397. doi:10.1056/NEJMoa032804
Dow, W. H., Brenes, G. y Rosero, L. (2013). CRELES: Costa Rican Longevity and Healthy Aging Study, Retirement Cohort. Methods, Wave 1. Berkeley, CA: Department of Demography, University of California. Recuperado de http://www.creles.berkeley.edu/pdf/Methods_w3.pdf
Fröhlich, M., Imhof, A., Berg, G., Hutchinson, W. L., Pepys, M. B., Boeing, H., ... Koenig, W. (2000). Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care, 23(12), 1835–1839. doi:10.2337/diacare.23.12.1835
García, P., Bulló, M., Balanzà, R., & Salas, J. (2006). C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. International Journal of Obesity, 30(3), 468-474. doi:10.1038/sj.ijo.0803182
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., . . . Costa, F. (2005). Diagnosis and management of the metabolic syndrome. Circulation, 112(17), 2735-2752. doi:10.1161/CIRCULATIONAHA.105.169404
Huang, J., Parish, R., Mansi, I., Yu, H., Kennen, E. M., Davis, T., & Carden, D. (2008). Non-high-density lipoprotein cholesterol in patients with metabolic syndrome. Journal of Investigative Medicine, 56(7), 931–936. doi:10.2310/JIM.0b013e318182080a
Koenig, W., Sund, M., Fröhlich, M., Fischer, H. G., Löwel, H., Döring, A., . . . Pepys, M. B. (1999). C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation, 99(2), 237-242. doi:10.1161/01.CIR.99.2.237
Mendall, M. A., Patel, P., Ballam, L., Strachan, D., & Northfield, T. C. (1996). C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ, 312(7038), 1061–1065. doi:10.1136/bmj.312.7038.1061
Nilsson, J. (2005). Crp - marker or maker of cardiovascular disease? Arteriosclerosis, Thrombosis, and Vascular Biology, 25(8), 1527-1528. doi:10.1161/01.ATV.0000174796.81443.3f
Pepys, M. B. (2005). Crp or not crp? that is the question. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(6), 1091-1094. doi:10.1161/01.ATV.0000169644.88847.28
Ridker, P. M. (2003). C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation, 108, 81-85. doi:10.1161/01.cir.0000093381.57779.67
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation, 107(3), 391-397. doi:10.1161/01.CIR.0000055014.62083.05
Ridker, P., Cushman, M., Stampfer, M., Tracy, R., & Hennekens, C. (1997). In- flammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336(14), 973-979. doi:10.1056/NEJM199704033361401
Ridker, P., Rifai, N., Rose, L., Buring, J., & Cook, N. (2002). Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347(20), 1557-1565. doi:10.1056/NEJMoa021993
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. (2004). C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation, 110(4), 380-385. doi:10.1161/ 01.CIR.0000136581.59584.0E
Saleh, N., Svane, B., Hansson, L. O., Jensen, J., Nilsson, T., Danielsson, O., & Tornvall, P. (2005). Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clinical Chemistry, 51(11), 2124–2130. doi:10.1373/clinchem.2005.048082
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S., Haffner, S. M., ... Shepherd, J. (2003). Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study. Circulation, 108(4), 414-419. doi:10.1161/01.CIR.0000080897.52664.94
Tracy, R. P., Psaty, B. M., Macy, E., Bovill, E. G., Cushman, M., Cornell, E. S., & Kuller, L. H. (1997). Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(10), 2167-2176. doi:10.1161/01.ATV.17.10.2167
Wilson, P.W.F., D’Agostino, R. B., Levy, D., Belanger, A. M., & Silbershatz, H. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97, 1837-1847. doi:10.1161/01.CIR.97.18.1837
Yang, T., Chu, C., Hsieh, P., Hsu, C., Chou, Y., Yang, S., . . . Sun, C. (2013, 4). C-reactive protein concentration as a significant correlate for metabolic syndrome: A Chinese population-based study. Endocrine, 43(2), 351–359. doi:10.1007/s12020-012-9743-7
Ye, X., Yu, Z., Li, H., Franco, O. H., Liu, Y., & Lin, X. (2007). Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. Journal of the American College of Cardiology, 49(17), 1798-1805. doi:10.1016/j.jacc.2007.01.065
Yudkin, J. S., Stehouwer, C. D., Emeis, J. J. y Coppack, S. W. (1999). C-reactive pro- tein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology, 19(4), 972-978. doi:10.1161/01.ATV.19.4.972
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 UNED Research Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Note: This abstract contains an incorrect copyright due to technical issues. Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal
All journal contents are freely available through a CC BY 4.0 license.
CC BY 4.0 is a Creative Commons: you can copy, modify, distribute, and perform, even for commercial reasons, without asking permission, if you give appropriate credit.
Contents can be reproduced if the source and copyright are acknowledged according to the Open Access license CC BY 4.0. Self-storage in preprint servers and repositories is allowed for all versions. We encourage authors to publish raw data and data logs in public repositories and to include the links with all drafts so that reviewers and readers can consult them at any time.
The journal is financed by public funds via Universidad Estatal a Distancia and editorial independence and ethical compliance are guaranteed by the Board of Editors, UNED. We do not publish paid ads or receive funds from companies.